"Rift Valley fever virus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A mosquito-borne species of the PHLEBOVIRUS genus found in eastern, central, and southern Africa, producing massive hepatitis, abortion, and death in sheep, goats, cattle, and other animals. It also has caused disease in humans.
Descriptor ID |
D012296
|
MeSH Number(s) |
B04.820.087.710.700
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Rift Valley fever virus".
Below are MeSH descriptors whose meaning is more specific than "Rift Valley fever virus".
This graph shows the total number of publications written about "Rift Valley fever virus" by people in this website by year, and whether "Rift Valley fever virus" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2013 | 1 | 0 | 1 |
2016 | 1 | 0 | 1 |
2019 | 1 | 1 | 2 |
2022 | 1 | 0 | 1 |
2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Rift Valley fever virus" by people in Profiles.
-
Bracci N, Baer A, Flor R, Petraccione K, Stocker T, Zhou W, Ammosova T, Dinglasan RR, Nekhai S, Kehn-Hall K. CK1 and PP1 regulate Rift Valley fever virus genome replication through L protein phosphorylation. Antiviral Res. 2024 Jun; 226:105895.
-
Watts DM, Westover JLB, Palermo PM, Bailey KW, Morrill JC, Bettinger GE, Monath TP, Smith DR, Peters CJ, Pittman PR, Orbegozo J, Gowen BB. Estimation of the Minimal Rift Valley Fever Virus Protective Neutralizing Antibody Titer in Human Volunteers Immunized with MP-12 Vaccine Based on Protection in a Mouse Model of Disease. Am J Trop Med Hyg. 2022 11 14; 107(5):1091-1098.
-
Salekwa LP, Wambura PN, Matiko MK, Watts DM. Circulation of Rift Valley Fever Virus Antibody in Cattle during Inter-Epizootic/Epidemic Periods in Selected Regions of Tanzania. Am J Trop Med Hyg. 2019 08; 101(2):459-466.
-
Nyundo S, Adamson E, Rowland J, Palermo PM, Matiko M, Bettinger GE, Wambura P, Morrill JC, Watts DM. Safety and immunogenicity of Rift Valley fever MP-12 and arMP-12?NSm21/384 vaccine candidates in goats (Capra aegagrus hircus) from Tanzania. Onderstepoort J Vet Res. 2019 Jan 31; 86(1):e1-e8.
-
Baer A, Shafagati N, Benedict A, Ammosova T, Ivanov A, Hakami RM, Terasaki K, Makino S, Nekhai S, Kehn-Hall K. Protein Phosphatase-1 regulates Rift Valley fever virus replication. Antiviral Res. 2016 Mar; 127:79-89.
-
Xu W, Watts DM, Costanzo MC, Tang X, Venegas LA, Jiao F, Sette A, Sidney J, Sewell AK, Wooldridge L, Makino S, Morrill JC, Peters CJ, Kan-Mitchell J. The nucleocapsid protein of Rift Valley fever virus is a potent human CD8+ T cell antigen and elicits memory responses. PLoS One. 2013; 8(3):e59210.